All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for NEURELIS, INC. · Biopharmaceutical company specializing in treatments for neurological conditions.

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 17, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).

Bills named in this filing 2

H.R. 7383
Improving Access to Health Care in Rural and Underserved Areas Act
S. 1214
RARE Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.